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INTRODUCTION
The influenza A (H1N1) resurgence was identified in
April of 2009 in North America, 35 years after its initial
description.1 Since then, cases of influenza A (H1N1) have
been reported on all continents, with the clinical presenta-
tion ranging from mild symptoms (runny nose, fever,
cough, and myalgia) to acute respiratory distress syndrome
(ARDS).2-4 Approximately 75% of patients with influenza A
(H1N1) admitted to an intensive care unit (ICU) required
invasive mechanical ventilation,5 one-third of whom pro-
gressed to refractory hypoxemia and needed rescue
ventilation techniques, including alveolar recruitment man-
euvers, ventilation in the prone position, high-frequency
ventilation, extracorporeal membrane oxygenation, or
inhaled nitric oxide.6-7 In addition to the ventilatory
support, treatment for respiratory failure due to influenza
A (H1N1) includes antiviral agents, which should be
initiated at the time of clinical suspicion, preferably within
48 hours of the onset of symptoms. We describe herein the
case of a patient with ARDS secondary to influenza A
(H1N1) on whom recruitment maneuvers and ventilation in
the prone position were used for the treatment of refractory
hypoxemia, along with corticosteroids, oseltamivir, and
intravenous zanamivir.
CASE REPORT
A 63-year-old woman from Campinas, SP, Brazil was
admitted to the ICU on August 21, 2009 (Day 1) because of
respiratory failure. She had a five-day history of dry cough,
myalgia, wheezing, and fever (38 C˚) and had been using
clarithromycin for three days. Her past medical history was
significant for hypertension, type 2 diabetes mellitus,
obesity (body mass index of 30.1 kg/m2), and total hip
replacement 10 months before admission complicated by
deep-vein thrombosis (DVT) and pulmonary embolism,
both of which were successfully treated. Upon admission,
she was placed in respiratory isolation with negative
pressure, and nasopharyngeal washings were collected for
detection of influenza A (H1N1) by reverse-transcriptase
polymerase chain reaction (RT-PCR). The blood and
tracheal aspirate cultures were negative, as was the urinary
assessment for Pneumococcus and Legionella. Arterial blood
gas analysis confirmed severe hypoxemia, and an X-ray
computed tomography (CT) scan (Figure 1) of the thorax
showed bilateral pulmonary infiltrates.
Orotracheal intubation was performed after a failed
attempt at noninvasive ventilation. Oseltamivir (150 mg
b.i.d.) administered through the enteral route and intrave-
nous ceftriaxone (1 g IV b.i.d.), levofloxacin (500 mg IV q.d.),
vancomycin (1 g IV b.i.d.) and methylprednisolone (2 mg/
kg/day) were started. A Doppler ultrasound of the lower
limbs was negative for DVT, and an echocardiogram
showed a systolic pulmonary artery pressure of 26 mm
Hg with no signs of right ventricular dysfunction and a left
ventricular ejection fraction of 66%.
Severe hypoxemia (PaO2 55 mm Hg) was present despite
ventilation with a positive end-expiratory pressure (PEEP)
of 16 cm H2O and pure oxygen, so a recruitment maneuver
was performed for two minutes using a PEEP of 35 cm H2O
and a plateau pressure of 50 cm H2O. After the recruitment,
the PEEP was titrated at 18 cm H2O according to the best
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Figure 1 – X-ray computed tomography of the thorax showing
diffuse, patchy bilateral ground glass opacities and consolidation
at ICU admission.
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dynamic compliance, but there was no significant improve-
ment in the PaO2/FiO2 ratio (Figure 2). A decision was then
made to repeat the recruitment maneuver with the patient
in the prone position, which resulted in significant improve-
ment in gas exchange (Figure 2). Mechanical ventilation in
the prone position for an average of 12 hours/day and one
daily recruitment maneuver were continued for three
consecutive days, with progressive improvement in the
gas exchange (Figure 2). At all times, we maintained a
protective ventilatory strategy with low tidal volumes
(6 mL/kg of ideal body weight) and a plateau pressure of
,30 cm H2O.
On the 12th day of her ICU stay, amantadine was added to
the treatment regimen, and importation of intravenous
zanamivir (not approved in Brazil) was requested because
the RT-PCR for influenza A (H1N1) remained positive. On
the 19th day of her stay in the ICU, intravenous zanamivir
was started, and the RT-PCR for influenza A (H1N1)
became negative two days later. Because the patient still
had diffuse, patchy ground-glass opacities on chest CT and
had signs of incipient interstitial fibrosis, pulse therapy with
methylprednisolone (1 g/day) for three consecutive days
was given. The patient showed progressive radiological and
gas exchange improvement and was released from mechan-
ical ventilation 26 days after intubation. She was discharged
from the ICU 30 days after admission and discharged home
3 weeks later.
DISCUSSION
We reported the successful use of mechanical ventilation
in the prone position combined with recruitment maneuvers
as rescue therapies for refractory hypoxemia in a patient
with ARDS due to influenza A (H1N1). We also described
the use of intravenous zanamivir in a patient with persis-
tently positive RT-PCR for influenza A (H1N1).
Because of high suspicion during the southern hemi-
sphere epidemic, even nonspecific symptoms of dry cough,
fever, and myalgia triggered the application of our protocol
for managing influenza A (H1N1) at our institution. The
protocol includes respiratory isolation (negative pressure
and use of an N95 mask by health professionals) to prevent
in-hospital transmission of the virus, collection of respira-
tory specimens for RT-PCR, and immediate therapy with
oseltamivir. It is noteworthy that the rapid test for antigen in
nasopharyngeal secretions was negative for the patient
described here. The rapid test results are available in
15 minutes, but they have a low sensitivity (20%–30%),
and a negative result should not rule out influenza A
(H1N1) or lead to discontinuation of the respiratory
isolation procedures. The RT-PCR (sensitivity of 98%),
available within six hours, was positive for the oropharyn-
geal washings and tracheal secretions. Alternatively, viral
culture could have been performed, which has a sensitivity
of 89% and available results in two to three days.4
Treatment with antiviral drugs should be started early in
serious cases, even before diagnostic confirmation, prefer-
ably within 48 hours of the onset of symptoms, because the
delay in instituting such treatment may contribute to
increased disease severity.3 The use of neuraminidase
inhibitors (oseltamivir and zanamivir) is preferable to the
use of adamantanes (rimantadine and amantadine) because
of the increased resistance of the virus to the latter class of
drugs;2 the combination of an adamantane with a neur-
aminidase inhibitor is recommended by the World Health
Organization. In the present case, the RT-PCR remained
positive after 12 days of enteral oseltamivir at twice the
recommend dose, which led us to add amantadine and later
replace oseltamivir with intravenous zanamivir.2
The association of recruitment maneuvers with prone
positioning was crucial to the management of the hypox-
emia, serving as a bridge to the recovery of the lungs.
Alveolar damage associated with necrotizing bronchiolitis
with extensive hemorrhage has been described as the major
histological pattern for patients with H1N1 pneumonia and
respiratory failure,8 and we believe that this type of injury
can be limited by alveolar recruitment interventions such as
RM, prone positioning, and corticosteroid use. Recruitment
maneuvers in ARDS, through the application of high
inspiratory pressures for short periods of time1, can be
used to open collapsed alveoli and allow a more homo-
geneous distribution of the ventilation, potentially reducing
the lung injury induced by mechanical ventilation.
Mechanical ventilation in the prone position can be used
as a rescue therapy for patients with refractory hypoxemia.7
Prone positioning leads to better oxygenation by facilitating
the recruitment of collapsed alveoli in the dorsal regions of
the lungs and through the improvement of the ventilation/
perfusion matching caused by a shift in pulmonary
perfusion to the ventral regions. The prone position requires
training of the ICU staff, particularly with regard to the
proper and safe positioning of patients, tubes, and catheters
during position changes. We successfully combined the use
of recruitment maneuvers with prone positioning to
optimize gas exchange in our patient, a strategy seldom
described in the literature.10 Other therapeutic options
would have been inhaled nitric oxide, high-frequency
ventilation, and extracorporeal membrane oxygenation.
This case report illustrates the presentation of severe
pneumonia caused by influenza A (H1N1) and the
ventilatory and pharmacological measures that can be
adopted for the treatment of ARDS associated with
refractory hypoxemia.
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